CME Group

CME · NYSE · Financials · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$5.6B$5.6B$6.1B$6.1B$6.5B$6.5B62.5% margin62.5% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$1.5B$1.5B$1.5B$1.5B$1.6B$1.6B$1.6B$1.6B$1.7B$1.7B$1.5B$1.5B$1.9B$1.9B$1.7B$1.7B61.1% margin61.1% marginRevenueNet margin

Revenue (FY2025)

$6.5B

Net margin

62.5%

ROE

14.2%

Revenue CAGR (2y)

+8.1%

Profit CAGR (2y)

+12.4%

EPS (FY2025)

11.16

Net profit (FY2025)

$4.1B

Ask MarketChacha about CME

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Sep 2, 2026

    CME shares fell 3.03% in line with the broader market sell-off driven by rising oil prices (from U.S. strikes on Iran), higher Treasury yields, and increased odds of a near-term Fed rate hike.

    source 1source 2· confidence: medium
  • Jul 22, 2026

    CME Group reported Q2 2026 results that beat estimates with record market data growth and strong H1 performance, per its July 22 8-K and multiple contemporaneous reports.

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$6.5B$4.1B11.1662.5%14.2%
FY2024$6.1B$3.5B9.6757.5%13.3%
FY2023$5.6B$3.2B8.8657.8%12.1%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$1.7B$1.0B2.8861.1%
2026Q1$1.9B$1.2B3.1861.4%
2025Q3$1.5B$908.0M2.4959.1%
2025Q2$1.7B$1.0B2.8160.6%
2025Q1$1.6B$956.2M2.6258.2%
2024Q3$1.6B$912.8M2.5057.6%
2024Q2$1.5B$883.2M2.4257.6%
2024Q1$1.5B$855.2M2.3557.5%
2023Q3$1.3B$750.2M2.0656.1%
2023Q2$1.4B$777.6M2.1457.2%
2023Q1$1.4B$883.8M2.4361.3%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.